高级检索
HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition

    作者

    Xu, JW;Zhang, X;Wang, HL;Ge, SJ;Gao, TH;Song, L;Wang, XX;Li, H;Qin, YJ;Zhang, ZH

    作者单位

    [Xu, Jiawen; Song, Lin; Qin, Yejun] Shandong Univ, Shandong Prov Hosp, Dept Pathol, 324 Weiqi Ave,Jingwu Rd, Jinan 250021, Shandong, Peoples R China.;-;[Zhang, Xi] Shandong Univ, Shandong Prov Hosp, Dept Breast & Thyroid Surg, Jinan 250021, Shandong, Peoples R China.;-;[Wang, Hongliang] Shandong Acad Med Sci, Shandong Acad Occupat Hlth & Occupat Med, Jinan 250062, Shandong, Peoples R China.;-;[Ge, Shujian] Shandong Univ, Shandong Prov Hosp, Dept Sci & Educ, Jinan 250021, Shandong, Peoples R China.;-;[Gao, Taihong] Shandong Univ, Shandong Prov Hosp, Dept Neurosurg, Jinan 250021, Shandong, Peoples R China.;-;[Wang, Xinxing] Shandong Univ, Shandong Prov Hosp, Dept Hepatobiliary Surg, Jinan 250021, Shandong, Peoples R China.;-;[Li, Hui] Qingdao Univ, Affiliated Hosp, Dept Nursing, Qingdao 266071, Shandong, Peoples R China.

    摘要

    Hepatocellular carcinoma related protein 1 (HCRP1), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several tumors and strongly affects the outcomes of cancer patients. It is reported the expression of HCRP1 is inversely related to epidermal growth factor receptor (EGFR) in breast cancer and lead to resistance to cetuximab in ovarian cancer. However, its exact mechanism in the progression of Hepatocellular carcinoma (HCC) remains unknown. Herein, HCRP1 expression and its clinical significance were examined in 101 HCC patients using immunohistochemistry. Cell proliferation, migration and invasion assays were conducted in HCC cell lines. EGFR activation and degradation were then observed after EGF inducing in HCRP1 knockdown HepG2 cells. In addition, we also detected whether epithelial-to-mesenchymal transition (EMT) was involved in the malignancy promoted by HCRP1. The results showed that 59 of the 101 HCC cases exhibited downregulation of HCRP1 expression (P < 0.01) as compared to 30 benign liver lesions and 20 normal liver tissues, all of which showed a high level of HCRP1. HCRP1 expression was significantly related to age (P = 0.017), pathological grade (P = 0.003), tumor encapsulation (P = 0.037), recurrence (P = 0.039) and death (P = 0.015), but unrelated to cirrhosis (P = 0.216), tumor size (P = 0.273), and distant metastasis (P = 0.554). Lower HCRP1 expression was correlated with shorter RFS and OS (P < 0.001), and decreased HCRP1 level is an independent prognostic marker in HCC patients (P < 0.05). Overexpression of HCRP1 decreased and knockdown increased HCC cell proliferation, migration and invasion. HCRP1 depletion increased EGFR activation and inhibited EGFR degradation. EMT phenotype was promoted after HCRP1 downregulation via increase of Snail and Twist1 and activation of Akt phosphorylation in HepG2 cells. Conversely, upregulation of HCRP1 in SMMC-7721 cells led to the opposite effect. In conclusion, our study indicated that downregulation of HCRP1 is a valuable prognostic factor involved in EGFR regulation and acquisition of the mesenchymal phenotype of HCC cells. (C) 2017 Elsevier Masson SAS. All rights reserved.

    关键词

    CANCER-CELLS; EXPRESSION; METASTASIS; GROWTH; PROLIFERATION; PROGNOSIS; RNA; EMT
基本信息

  • 所属机构:病理科

    归属医师: 徐嘉雯 宋琳 葛树建 王新兴 覃业军

    PMID:28122307

    UT:000395528000048

    刊名:BIOMEDICINE & PHARMACOTHERAPY

    年,卷(期):2017年88卷

    页码:421-429

    DOI:10.1016/j.biopha.2017.01.013

    附件: pdf

    收录:   SCIE